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Summary 
Cross-linking the receptors for the Fc domain of IgG (Fc~/R) on leukocytes induces activation 
of protein tyrosine kinases.  The intermediary molecules that transduce to the nucleus the sig- 
nals leading to induction of the diverse biological responses mediated by these receptors are not 
clearly identified. We have investigated whether mitogen-activated protein kinases  (MAPK) 
are involved in transmembrane signaling via the three Fc~/R present on monocytic, polymor- 
phonuclear, and natural killer (NK)  cells.  Our results  indicate that occupancy of FcyRI and 
FcyRII on the monocytic cell line THP-I and on polymorphonuclear leukocytes (PMN) in- 
duces,  transiently and  with  fast  kinetics,  MAPK phosphorylation, as  indicated by decreased 
electrophoretic mobility in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and in- 
creased amounts of the proteins in antiphosphotyrosine antibody immunoprecipitates. This, as- 
sociated with increased enzymatic activity, also occurs upon stimulation of the transmembrane 
isoform of CD16 (FcyRIIIA) in NK cells and in a T  cell line expressing transfected Fc'yRIIIA 
ct ligand-binding chain in association with ~, but not upon stimulation of the glycosil-phos- 
phatidylinositol-anchored FcyRIIIB on PMN. Using the specific MAP kinase kinase inhibitor 
PD 098059, we show that activation of  MAPK is necessary for the Fc~/R-dependent induction 
of c-fos and tumor necrosis factor e~ mRNA expression in monocytes and NK cells. These re- 
suits underscore the role of MAPK as signal-transducing molecules controlling the expression 
of different genes relevant to leukocyte biology upon Fc~R stimulation. 
M 
itogen-activated protein kinases (MAPK) 1, also known 
as extracellular signal-regulated kinases  (ERK), trans- 
duce signals  elicited via several receptors that  either have 
intrinsic tyrosine kinase activity or are associated with non- 
receptor tyrosine kinases  (1),  including hematopoietic re- 
ceptors like FceRI,  TCR,  and B  cell receptor (BCR)  (2, 
3). MAPK are serine-threonine kinases activated by MAPK 
kinases  (MEK), that phosphorylate the TEY domain on ty- 
rosine  and  threonine  residues  (4).  Stimuli  that  activate 
MAPK induce a signaling cascade involving transient for- 
mation of ras-GTP  and activation of rafkinase at the mem- 
brane,  followed  by  sequential  activation  of  MEK  and 
IAbbreviations used in this paper." BCR, B cell receptor;  [Ca2+]i, intracellular 
Ca  2+ concentration;  EA, IgG-sensitized  E; ERK, extracellular  signal-reg- 
ulated kinase; FBS, fetal bovine serum; Fc~/R, receptor for the Fc flag- 
ment of IgG; GaMIg, goat anti-mouse Ig; GPI, glycosil-phosphatidyli- 
nositol;  ITAM, inmmne receptor tyrosine-based activation motit~ 
MAPK, mitogen-activated  protein kinase; MBP, myelin basic protein; 
MEK, MAP kinase kinase; PI-3K, phosphatidylinosito|-3 kinase; PLC, 
phospholipase C. 
MAPK (5).  Several transcription factors have been identi- 
fied in  eukaryotic cells  as  targets  of MAPK  (6).  The  ras- 
MAPK  pathway mediates c-los induction, via phosphoryla- 
tion of the transcription factor TCF/Elkl  (ternary complex 
factor) (7). MAPK also activate cytoplasmic enzymes (e.g., 
phospholipase A2) or other proteins regulating protein syn- 
thesis  (8, 9),  and have been implicated in proliferative re- 
sponses and differentiation (10). 
Receptors for the  Fc  domain  of IgG  (FcyR)  link  hu- 
moral and cellular immune responses and mediate different 
functions upon ligand binding (11).  Three different classes 
of FcyR  have  been  identified,  FcyRI  (CD64),  FcyRlI 
(CD32), and FcyRIII (CD16), that differ in relative affinity 
for IgG,  cellular distribution,  and  molecular composition 
(11). Cross-linking Fc',/Rs on macrophages, PMN, and NK 
cells induces signals leading to the activation of diverse bio- 
logical responses such as phagocytosis, Ab-dependent cellu- 
lar cytotoxicity, and transcription of genes encoding cyto- 
kines and surface molecules relevant to leukocyte functions 
(12,  13). 
Initiation of signal transduction after occupancy of FcyR 
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shares common molecular mechanisms involving sequential 
activation of tyrosine kinases of the src and Syk families, de- 
pending on induced phosphorylation of immune  receptor 
tyrosine-based  activation  motifs  (ITAM)  (14-16).  In  the 
lFN-y-inducible high affinity FcyRI and in the low affin- 
ity FcyRIIIA, ITAM is present  in the  ~ family members 
(~  only or ",/ and ~ chains  in myelomonocytic and in NK 
cells,  respectively)  linked  as dimers to the  highly homolo- 
gous ligand-binding cx chains (17,  18).  The ITAM motif in 
the  0~ chain's cytoplasmic domain of the low affinity Fcy- 
RIIA in monocytes/macrophages and PMN  confers signal 
transduction capability to the ix chain itself (19). It has been 
demonstrated  that this chain is expressed  and functional at 
the cell membrane independently from association with ad- 
ditional molecules (19). Whether or not the glycosil-phos- 
phatidylinositol  (GPI)-linked  Fc-/RIIIB  on  PMN  trans- 
duce signals is still  controversial, but the recent observation 
that hck is activated after Fc~RIIIB cross-linking supports a 
signal-transducing  capability  of this  receptor  (20).  Activa- 
tion of protein tyrosine kinases  results  in tyrosine phosphor- 
ylation and activation of cellular substrates  (21, 22), among 
which phospholipase C  (PLC) 11  and y2, followed by in- 
creased intracellular  Ca  2+  concentration  ([Ca2+]i)  (23,  24). 
Activation  of phosphatidylinositol-3  kinase  (PI-3K)  also 
occurs upon tyrosine kinase activation (25, 26). 
A  major event in the activation of myelomonocytic and 
NK cells induced by Fc-/R-generated signals is the induced 
expression of genes encoding cytokines (12,  13). Recently, 
p21 ~-~ activation has been observed  upon FcyRIIIA occu- 
pancy in  NK ceils  (27).  In T  cells,  TCR-mediated  p2D  's 
activation  is  necessary  for  ERK2  activation  and  TCR- 
induced transcription  of IL-2 mRNA  (28,  29).  However, 
no  formal  proof exists  that  ERK2  links  p2F  ''s activation 
with IL-2 gene induction. 
Here,  we  analyzed  the  involvement  of MAPK  in  the 
signal  transduction  pathways  elicited  upon  FcyR  cross- 
linking. Our data show that occupancy of each of the trans- 
membrane Fc~/tt, fomls, but not of the GPI-linked Fc',/1MIIB, 
induces  MAPK activation.  A  role for this  kinase(s)  in the 
Fc',/R.-mediated induction  of c-los  and  TNF-ix  mRNA  is 
demonstrated  using the  MEK inhibitor  PD 098059  to in- 
hibit, in leukocytes, expression of these genes. These results 
identify  MAPK  as  common  intermediate  molecules  in 
FcyR-induced activation of several genes relevant  to leu- 
kocyte's functions. 
Materials  and Methods 
Cell Lines and Primary Cell Preparations.  The  human  mono- 
cytic THP-1 and B lymphoblastoid P,  PMI-8866, and the routine 
mAb-producing hybrid B cell lines were maintained in culture in 
RPMI-1640 medium (BioWhittaker, Walkersville,  MD) supple- 
mented  with  10%  heat-inactivated  fetal  bovine  serum  (FBS; 
Sigma Chemical Co., St. Louis, MO) and 100 Ixg/ml glutamine. 
Fc'yRIIIA-transfected  CD3-/CD2-J32.65.3.I Jurkat T cells, ex- 
pressing  Fc',/P,  IIlAc~  chain  in  association  with  endogenous 
chain,  was maintained  in  culture  in R_PMI-1640  supplemented 
with  10% heat-inactivated,  protein G-adsorbed FBS and geneti- 
cin (G418;  GIBCO BRL, Gaithersburg,  MD) (23). PBMC, sep- 
arated  on  Ficoll-Hypaque  (F/H)"  (Histopaque-1077,  Sigma 
Chemical  Co.)  density  gradient  from  heparin  anticoagulated 
venous peripheral  blood of healthy donors, were depleted  of the 
majority  of monocytes aider adherence  to  plastics  (1  h,  37~ 
PMN were obtained from the F/H pellet  of the upper two thirds 
of leukocyte-rich plasma  after  sedimentation  (30 rain,  37~  of 
total  peripheral  blood  with  Dextran  T500  (Phamlacia  Biotec, 
Uppsala,  Sweden; 3% Dextran in PBS/blood, vol/vol) (30). Al- 
ternatively,  PMN were collected from the pellet  of F/H density 
gradients  of total  blood, resuspended  in autologous plasma  and, 
after E sedimentation as above, they were recovered in the pellet 
of a second F/H gradient  performed to deplete  PBL and mono- 
cyte contaminants.  If needed,  contaminating E were eliminated 
after  lysis with  0.15  M  NH4CI,  0.(31 M  KHCO~,  and  1 mM 
EDTA, pH 7.3. PMN represented >99% of the cell preparations, 
as determined by morphological examination and surface pheno- 
typing in  indirect  imnmnofluorescence  (flow  cytometry)  using 
anti-CD15 mAb B40.9 (31). Monocyte (CDI4 + cells) contami- 
nation was undetectable.  When indicated,  PMN were used after 
16 h of incubation (S ￿  lff' cells/ml RPMI-10% FBS) with  103 
U/nil  rlFN-~/  (Genentech Inc., South San  Francisco,  CA; 7  ￿ 
107 antiviral  U/rag on HeLa cells) as previously described  (30). 
IFN-y-treated PMN were >99% FcyP,.I  +, as detected by immu- 
nofluorescence  using murine IgG2a or anti-FcyRI mAb 32.2 (32). 
Homogeneous NK cell preparations  were obtained from l(I-d 
cocultures of PBL with 30 Gy-irradiated RPMI-8866 cells after 
negative  selection  using a mixture of anti-CD14, anti-CD3, and 
anti-CD5 mAb and indirect antiglobulin  rosetting (33). The pu- 
rity of each preparation (>98% CD 16 +/CD56 +  / CD3- and < 1% 
CD3 + cells) was confimaed by indirect  immunofluorescence (flow 
cytometry) using a panel ofmAb. 
Abs.  mAb  B52.1  (anti-CD14,  IgM),  B36.1  (anti-Cl)5, 
IgG2b),  OKT3  (anti-CD3,  IgG2a),  3G8  (anti-CD16,  IgG1), 
B159.5  (anti-CD56,  IgGl),  IV.3  (anti-CD32,  IgG2b),  B137.17 
(IgG2a),  32.2  (anti-CD64,  lgG2a),  and B40.9 (anti-C1)15,  lgM) 
have been previously described  (33-35).  IgG were  purified  on 
protein  G-Sepharose  colunms  (Pierce,  Rockford,  IL). Fab  and 
F(ab')2  fragments  were  prepared  following  standard  protocols 
(36).  Undigested IgG and Fc fragments  were depleted after  ad- 
sorption  to protein  G-Sepharose,  and the  Ab purity was  con- 
firmed in SDS-PAGE. Labeling  with  N-hydroxysuccinimidobi- 
otin (Pierce) was according to standard procedures (37). The goat 
anti-mouse  lg  (GecMIg) was  produced  in  our  laboratory,  ad- 
sorbed  on  human  lg,  and  affinity  purified  on  a  mouse  lgG- 
Sepharose  4B  colunm  (Pharmacia  Biotech).  Rabbit  anti-mouse 
Ig serum  (RoLMIg) was  obtained from Cappel  (Durham,  NC). 
The polyclonal rabbit serum ERK2 (anti-MAPK EFkK2), and the 
antiphosphotyrosine  murine  mAb  PY20  were  obtained  from 
Santa Cruz Biotechnology (Santa Cruz, CA). The polyclonal rab- 
bit serum t),2 (anti-MAPK EKKI  and ERK2), and the routine 
antiphosphotyrosine  mAb  4G10  were  purchased  from  Upstate 
Biotechnolog,/, Inc. ([UBI] Lake Placid, NY). 
Cell Stimulation.  Cells  were  incubated  (5-10  X  l(l~'/ml) for 
the indicated  times at 37~  in serum-free medium containing 10 
Ixg/ml Fc~P,.-specific  or irrelevant  control mAb and 5(1  txg/ml 
streptavidin  (Sigma Chemical Co.) or 20 txg/ml GciMIg, as ap- 
propriate. When indicated,  the cells were first incubated with the 
biotin-labeled mAb (10 rain on ice), washed,  and resuspended  in 
medium  containing  streptavidin;  results  were  identical.  Cells 
stimulated  with 50 ng/ml PMA (Sigma Chemical Co.) were used 
as positive control. Immune complexes (rabbit IgG-sensitized  bo- 
1028  Fc3,R-induced  MAPK Activation and Gene Expression Figure 1.  Presence  ofERK kinases in the antiphosphotyrosine immu- 
noprecipitates from THP-1  cells. THP-1  cells (15  ￿  10a/sample) were 
incubated (2 rain, 37~  in serum-free medium without  (None) or with 
reagents indicated (biotin labeled) and streptavidin. Phosphotyrosiue pro- 
teins were precipitated with mAb PY20 from NP-40  lysates of the cells 
and resolved in 7.5% SDS-PAGE. Western blot analysis  was performed, 
sequentially on  the same filter, using antiphosphotyrosiue (PY, top) and 
anti-MAPK  ERKI  and ERK2  Ab (bottom) 4G10 and R2,  respectively. 
Experiment representative of three performed with identical results. 
mM  Tris,  pH  7.5,  0.05  M  NaC1  supplemented  with  1  mM 
Na3VO  4,  and  5  mM  benzamidine. After adding 30  p~l reaction 
buffer (30 mM Hepes,  10 mM MgC12, 1 mM dithiothreitol, 20 
F~M ATP,  10  ~Ci  ",/-[32p]ATP  {4,000  Ci/mmol,  sp  act; ICN 
Pharmaceuticals, Inc., Costa Mesa, CA], 5 mM benzamidine, 5 big 
myelin basic protein [MBP;  Sigma Chemical Co.  or UBI]), the 
reaction was performed for 30 min at 30~  Eluted products were 
analyzed on 13% SDS-PAGE and transferred to nitrocellulose fil- 
ters. Western blot with ERK2 Ab was performed on the filter to 
verify the amounts of MAPK precipitated from each sample. In 
vitro phosphorylation of MBP  was visualized after exposure of 
the  filters or  dried gels  to  X-AR  films  (Eastman  Kodak  Co., 
Rochester, NY).  Levels of phosphorylation were quantitated by 
optical densitometry (Personal Densitometer SI, Molecular Dy- 
namics Inc., Sunnyvale, CA). 
Northern Blot Analysis.  Total  RNA  was  extracted  as  previ- 
ously described using RNAzoi (Biotecx Laboratories, Houston, 
TX).  RNA  was  size  fractionated  in  1%  agarose-formaldehyde 
gels,  transferred  by  capillarity onto  Hybond-nylon  membranes 
(Amersham Corp.), and hybridized to cDNA probes specific for 
human TNF-ot , c-fos, and  ~32-microglobulin,  as described (40). 
RNA was  visualized in ethidium bromide-stained gels,  and the 
amount  of RNA  loaded was  determined after hybridization to 
]32-microglobulin  cDNA.  cDNA  probes  were  labeled  with 
cx-[32p]dCTP  (sp act 3,000  Ci/mmol; NEN  Dupont,  Wilming- 
ton,  DE)  by  random  priming  or  nick  translation  (Boehringer 
Mannheim Corp., Indianapolis,  IN). Filters were exposed to X-AR 
films for autoradiography. Levels of expression of each mRNA 
species were quantitated as above. 
vine erythrocytes [EA]) were prepared as described (13), nonsen- 
sitized bovine E were used as control. When indicated, cells were 
pretreated (30 min,  37~  with  the indicated concentrations of 
MEK inhibitor PD 098059 (38; kindly provided by Dr. A. Saltiel, 
Parke-Davis Pharmaceutical Research/Warner-Lambert Co., Ann 
Arbor, MI). 
Immunoprecipitation and Western Blotting.  These  were  performed 
as previously described (25);  lysis buffer was  10  mM Hepes, pH 
7.5, 0.15 M NaC1, 10% glycerol, 10 b~g/ml each aprorinin and leu- 
peptin, 1 mM PMSF, 1 mM Na3VO4,  and 1% NP-40. Abs cou- 
pled to protein A-Sepharose (Pharmacia Biotech) via RotMlg or 
not, as appropriate, were used for immunoprecipitation (2 or t8 h, 
4~  after preclearing with the same beads not coupled with Ab. 
Proteins  were  separated in  SDS-PAGE under  reducing  condi- 
tions. Western blot analysis was performed as previously reported 
(25),  and  Ab-reactive proteins were  detected  with  horseradish 
peroxidase-labeled donkey anti-rabbit or GcxM Ig and enhanced 
chemiluminesce (ECL; Amersham Corp., Arlington Heights, IL). 
When  indicated,  different  Abs  were  used  sequentially on  the 
same filter, after stripping (30 nain, room temperature, 0.1  M gly- 
cine/HCl, pH 2.6). 
MAPKAssay.  hnmunecomplex  MAPK  assays  were  per- 
formed as described by Thomas et al. (39). Briefly, cells (5 ￿  106/ 
sample) were tysed with 100 ~1 1% Triton X-100, 50 mM NaCI, 
10 mM Tris, pH 7.5, 50 mM NaF1, 1 mM PMSF, t mM Na3VO4, 
5 mM benzamidine, 1 mM EGTA, and 10 I,  zg/ml each aprotinin 
and  leupeptin.  MAPK  were  precipitated using  the  polyclonal 
ERK2 Ab (0.5-1  p~g Ab/sample) and protein A-Sepharose. The 
beads were washed four times in the same buffer and twice in  10 
Results 
MAPK Phosphorylation  and Activation after FcTRI and Fc  T- 
RII Stimulation.  Among  the  proteins  phosphorylated  on 
tyrosine  residues  after  FcyRI-ligand  (IgG2a)  binding  or 
Fc~/RII cross-linking with mAb tV.3  Fab and streptavidin 
in THP-1  cells is a set of proteins with an apparent molec- 
ular mass of,'o40 kD, similar to that of MAPK (Fig. 1, top). 
ERK1  and ERK2  were  detectable at  significant levels by 
Western immunoblotting in the PY20 antiphosphotyrosine 
immunoprecipitates  from  IgG2a-  or  anti-Fc',/RII-treated 
ceils (Fig.  1,  bottom).  Minimal levels of ERKI  and  ERK2 
were  present  in  the  same  immunoprecitates  from  control 
nonstimulated or IgG2a F(ab')z-stimulated cells. To  deter- 
mine  whether  MAPK  were  phosphorylated as  a  result of 
Fc~/R  occupancy,  Western  blot  analysis  was  performed 
with R2  antiserum on lysates of THP-1  cells treated with 
the  Fc2*RI-ligand (lgG2a)  or anti-Fc~RII mAb  IV.3  Fab 
and streptavidin (Fig. 2,  top).  ERK1  and ERK2  were  de- 
tected in both lysates as bands migrating slower than  those 
detected in controls. ERK2 appeared as a doublet in which 
the faster migrating band migrated as in controls. Decreased 
electrophoretic mobility indicates phosphorylation of both 
kinase isoforms after Fc'~R stimulation. The results of MAPK 
assays performed, with MBP as exogenous substrate, on the 
ERK2 immunoprecipitates from the same cell samples (Fig. 
2, bottom) revealed that MBP phosphorylation, detectable at 
minimal  levels  in  the  immunoprecipitates  from  control 
IgG2a F(ab')2-treated cells, was significantly increased (5  + 
2- and 4  +  1-fold increase, respectively; n  =  3)  in  those 
1029  Trotta et al. Figure 2.  ERK1 and ERK2 phosphorylation and activation of MAPK 
upon Fc~/R stimulation in THP-1  ceils.  THP-I cells were treated as in 
Fig. 1 and ERK2 was immunoprecipitated from 5 X 10" cell lysate equiv- 
alent; aliquots equivalent to I(}  r  cells were left untreated. (Top) Western 
blot analysis  (7.5% SDS-PAGE) was performed, with 13,2 Ab. (Bottom) Ki- 
nase assay  with MBP as exogenous substrate on the ERK2 immunopre- 
cipitates. Phosphorylation products were  resolved in  13% SDS-PAGE. 
Experiment representative of three performed with identical results. 
from  Fc~/RI-  or  FcyRII-stimulated cells, proving  activa- 
tion  of MAPK  enzymatic  activity. The  same  analysis was 
performed  in  PMN,  to  confirm  the  generality  of these 
findings,  and  to  determine  whether  the  GPl-anchored 
form  of  Fc~/RIII  mediates  similar  activation.  Electro- 
phorectic  mobility shift  of ERK2  was  detected in  freshly 
separated PMN  after  stimulation with  IV.3  Fab  or  PMA 
(Fig. 3,  top  left),  and significant MBP  phosphorylation was 
present in the ERK2  precipitates from the same cells (mid- 
dle  left),  but  undetectable  in  those  from  cells  stimulated 
with  either  IgG2a  or anti-CD16  mAb  F(ab')>  In  IFN- 
2~-treated PMN  (Fig. 3, right) ERK2 and MBP phosphory- 
lation were over basal levels in the lysates and in the ERK2 
immunoprecipitates both from Fc~/RII- and Fc~/RI-stimu- 
lated ceils. Western blot analysis with anti-ERK2 Ab con- 
firmed  the  presence  of equal  amounts  of ERK2  in  each 
precipitate used (Fig. 3, bottom). 
Kinetics of MAPK  Phosphotylation.  Western blot analysis 
with anti-ERK2 Ab was performed on NP-40  lysates pre- 
pared  from  IFN-y-treated PMN  at  different  times  after 
Fc',/RI and Fo/RII stimulation (Fig. 4).  In both cases, sig- 
nificant  levels  of  ERK2  phosphorylation  were  detected 
within  0.5-min  stimulation  and  declined  to  basal  levels 
within  32  min.  Similar results  were  obtained  in  THP-1 
cells (data not shown). 
MAPK Phosphorylation and Activation upon FcyRIIIA  Stim- 
ulation.  To determine whether all transmembrane Fo/R in- 
duce  activation  of MAPK,  similar experiments  were  per- 
formed in FcyRIIIA  + NK cells. Untreated or PMA-treated 
NK  cells were  used  as negative and  positive controls,  re- 
spectively. In lysates from  Fc',/RIIIA- or PMA-stimulated 
cells,  the  electrophoretic  mobility  of MAPK  ERK2  was 
decreased (Fig.  5,  top) and MBP  phosphorylation was  ob- 
served  in  immune  complex  kinase  assays  (Fig.  5,  middle); 
CD56  stimulation  was  ineffective  (not  shown).  Western 
blot analysis with anti-ERK2 Ab confirmed equal amounts 
of ERK2 in all precipitates (Fig. 5,  bottom).  MBP phosphor- 
ylation  in  ERK2  immunoprecipitates  from  Fc~RIIIA- 
stimulated cells was, on average, twofold that in precipitates 
from  untreated  or  control  CD56-treated  cells,  as  deter- 
mined  by  densitometry.  Similar results  were  obtained  in 
the Jurkat  T  cell line  expressing  transfected  Fc3,RIIIA ~x 
chain in association with { chain (data not shown). 
Role of MAPK in FcyR-induced Gene Expression.  Transcrip- 
tion of the immediate early gene c-jbs, a component of AP-I 
transcriptional  activator  (41),  is  rapidly  induced  upon 
MAPK activation. To  determine whether  c-fos  is induced 
upon  FcyR occupancy,  and whether MAPK are involved 
in its induction, expression ofc-Jbs  mRNA  was analyzed in 
THP-1  and NK cells, pretreated or not with the MEK in- 
hibitor  PD  098059  (38),  and  stimulated for  20  rain  with 
Figure 3.  Phosphorylation and activation 
of ERK2 upon FcyR stinmlation m PMN. 
PMN were incubated (5  X  10r  16 h, 
37~  in medium without  (None) or with 
IFN-y (500 U/ml),  as indicated, washed, 
and treated (2 min, 37~  with the indicated 
biotin-labeled  reagents (10  Ixg/ml) and 
streptavidin (50  Ixg/ml) or PMA  (5{) ng/ 
ml). NP-40  lysates were prepared and di- 
vided in two aliquots. ERK2 was imnmno- 
precipitated from 5 ￿  106 cell  equivalent ly- 
sates; an aliquot corresponding to  1{}  r' cells 
was left untreated. (Top) Western blot anal- 
ysis (7.5% SDS-PAGE) on total lysates  with 
anti-ERK2  Ab.  (Middle) MAPK assays on 
the ERK2 immunoprecipitates as in Fig. 2. 
(Bottom) Western blot analysis (13% SDS- 
PAGE) was performed on the same ERK2 
immunoprecipitates  with  anti-ERK2  Ab. 
Experiment  representative  of  nine  per- 
formed with identical results. 
1030  Fc',/R-induced MAPK Activation and Gene Expression Figure 4.  Kinetics ofMAPK phosphorylation  after FcyRl and II stim- 
ulation in IFN-y-treated PMN. IFN-~-treated PMN were incubated in 
medium without (None) or with biotin-labeled B137.17 IgG2a (top), IV.3 
Fab, and streptavidin (bottom), or PMA (50 ng/ml), as in Fig. 3. Identical 
aliquots of cells were collected at the indicated times and lysed with 1% 
NP-40. Western blot analysis was performed as in Fig. 3 on the lysates 
with EP-.K2 Ab. Experiment representative of  four performed with iden- 
tical results. 
immune complexes (EA). c-2bs mRNA was induced in both 
cell  types  after  FcyR  cross-linking,  and  its  induction  was 
almost completely inhibited in cells pretreated with 30 btM 
PD 098059  (Fig.  6,  top).  At this  concentration,  the inhibi- 
tor prevented  the induced phosphorylation and enzymatic 
activity  of ERK2  kinase  without  affecting tyrosine  phos- 
phorylation induced  upon Fc2/R  stimulation  (not shown). 
c-los mRNA  expression upon Fc2/R stimulation was inhib- 
ited by 83.2  -+- 8.0%  (n  =  3) and by 77.5  -2_ 3.5%  (n  =  2) 
in  PD  098059-pretreated  THP-1  and  NK  cells,  respec- 
tively, as detected by densitometric analysis. 
Cross-linking  of FcyR  induces  synthesis  of cytokines, 
including IFN-y, GM-CSF,  and TNF-cl in NK cells  (13), 
and IL-1, IL-6, and TNF-ot in monocytes (12).  The effect 
of the MEK inhibitor on the induction of TNF-0e nlRNA 
after  Fc2/R  occupancy  by  immune  complexes  was  ana- 
lyzed. Significant TNF-cx mRNA  levels were detectable in 
both THP-I and NK cells stimulated with EA for 2 or 1.5 h, 
respectively  (Fig.  7,  top),  but  not in  control E--stimulated 
cells.  The  induction  was  ahnost  completely  inhibited  in 
cells pretreated with PD 098059 (Fig. 7, top),  as determined 
by densitometric  analysis  (92.7  _+  8.9%  and  83.4  -+  8.1% 
inhibition,  n  =  3). 
Discussion 
Fc2/R-dependent signaling in monocytes, PMN, and NK 
cells  is initiated by receptor ligand occupancy  and results in 
the  activation  of src  (42,  43)  and  zeta-associated  protein 
(ZAP)-70-family  related  kinases  (44-46),  which  associate 
with  the  ITAM-containing  receptor  complex  subunits. 
Subsequent events include activation of PLC-2/1, -2/2 (23), 
and PI-3K (25, 26), increases in [Ca2+Ji and transcription of 
genes encoding cytokines  (13),  Protein  tyrosine kinase in- 
hibitors  block  these  events  (21,  23).  Here,  we  show  that 
activation of the MAPK ERK2 is also induced upon Fc2/R 
stimulation  and is  indispensable  for the  induced  transcrip- 
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Figure 5.  EIZK2  phosphorylation  and activation upon FcyRIIIA  stim- 
ulation. NK cells (5  ￿  10r'/ml)  were incubated in serum-free medium 
without (None) or with 3G8 (anti-FcyRlllA)  (10 gtg/ml) and G0eMIg  (20 
~g/ml), or PMA (50 ng/ml) for 1 min. NP-40 lysates were prepared and 
Western blot (top, 7.5% SDS-PAGE), and MAPK assay with MBP (mid- 
dle) were performed on EP,  K2 immnoprecipitates as in Fig. 2. Western 
blot analysis (bottom, 13% SDS-PAGE)  was performed on the same ER.K2 
immunoprecipitates with anti-ERK2 Ab. Experiment representative of 
four performed with identical results. 
tion  of early activation genes such  as  c-los,  and  cytokines, 
such as TNF-ot. 
Stimulation  of Fc2/RI and Fc2/t<II in the monocytic cell 
line THP-1  and U937  (not shown)  induces tyrosine phos- 
phorylation  of several  proteins  with  similar  apparent  mo- 
lecular  weights.  The  presence  of proteins  with  electro- 
phoretic  mobility  similar  to  that  of MAPK  in  the  total 
lysates  (not  shown)  and  in  antiphosphotyrosine  immuno- 
precipitates of Fc2/R-stimulated cells,  together with the no- 
tion that MAPK regulate gene induction  (6),  prompted us 
to examine  whether  these  kinases  were present  in the an- 
tiphosphotyrosine  precipitates  of  stimulated  cells.  Both 
ERK1  and ERK2,  the  best characterized MAPK isoforms 
in  mammalian  cells,  are  associated  with  antiphosphoty- 
rosine  precipitates,  indicating  that  MAPK  are  activated, 
likely after phosphorylation on threonine and tyrosine resi- 
dues (4),  and suggesting that they may play a role in Fc2/R- 
mediated  functions.  Induced  phosphorylation  of ElkK2 
was confirmed, based on its  decreased electrophoretic mo- 
bility in SDS-PAGE and increased  enzymatic activity.  Al- 
though  we  did  not  analyze  the  enzymatic  activity  of 
ER.K1,  the  induction  of its  phosphorylation  in  the  same 
conditions  supports  the hypothesis that this  isoform is  also 
activated.  Our studies  with  PMN  confirm the  results  ob- 
tained in THP-1 cells and demonstrate that Fc2/RI and Fc2/- 
RII occupancy induces MAPK activation in primary cells. 
The specificity of the reagents  used,  Fab,  F(ab')2, and avi- 
din,  assures  that in  each condition a single Fc2/R is stimu- 
lated;  the ability of each receptor to induce MAPK activa- 
tion was confirmed in both resting (Fc2/RI-/Fc2/RII +) and 
IFN-2/-treated (Fc2/RI+/Fc2/RII +) PMN. ERK2 phosphor- 
ylation is a transient event upon Fc2/R cross-linking, possi- 
bly because  a  phosphatase  is  induced,  upon  Fc2/K  cross- 
linking,  that  inactivates  MAPK  by  dephosphorylation,  in Figure  6.  c-fbs  mRNA induction upon 
Fc~/R stimulation. THP-1  (left) and  NK 
cells  (right)  were incubated in  serum-free 
medium for 30 rain with {}.3% DMSO (ve- 
hicle) (-) or 3{} }aM PD (}98(}59 (+). After 
stimulation with E or EA (20 rain, 37~ 
total  RNA  was  extracted. Northern  blot 
analysis was performed using o:fos  cDNA 
(top).  The blots were then stripped and hy- 
bridized to  ~2-microglobulm cDNA  (bot- 
tom).  Experiment  representative of  two 
(NK) and  three (THP-I  cells) performed 
with idenncal results. 
keeping  with  the  observation  that  MAPK  are  inactivated 
by the  dual  specificity phosphatase  PAC1,  specific for the 
tyrosine and threonine  residues  in  the  TEY motif of acti- 
vated MAPK (47). 
ERK2 kinase activation in Fc',/RIIIA-mediated signaling 
was evaluated in NK and Jurkat cells  constitutively express- 
ing  Fc~/RIIIA  (data  not  shown).  As  expected,  FcyRIIIA 
crosslinking  also  induced ERK2  phosphorylation  in  these 
cells,  thus demonstrating that activation of this kinase  rep- 
resents  a  common event  in  the  signal  transduction  medi- 
ated by each of the three transmembrane  Fc',/R. These re- 
ceptors share  common ITAM motifs, present  either in the 
cytoplasmic  domain  of the  0r  chain  (Fc~/RII)  or  in  the 
and  ~  o~  chain-associated  molecules  (48).  Although  Fc'y- 
RIIA has been reported to be expressed in association with 
~/chain in nmnocytes (49), our attempts to reproduce those 
data were negative  and our data indicate  no  association of 
FcyRII with  ",/  chain  (expressed  both  in  monocytes  and 
PMN;  18,  and  data not shown)  even  after receptor occu- 
pancy  (Trotta,  R.  and  B.  Perussia,  unpublished  results). 
The  experimental  protocol of Masuda  and Roos (49)  was 
complicated by the use of adherent cell populations, previ- 
ously  demonstrated  to  contain  NK  cells  (50)  and  of re- 
agents  that  may have  contained  contaminating Fc  capable 
of binding Fc~/RIII and Fc~/RI; thus, Fc~/RII-~/association 
may have been artifactual. Therefore, we favor the hypoth- 
esis  that Fc'yRIl is not associated  to  other signal transduc- 
tion chains as previously suggested (18), and that the ITAM 
sequence in the Fc~RIIA ot chain is sufficient to transduce 
the early events mediated via this receptor (19, 51). MAPK 
transduce  signals  from  other  hematopoietic  receptors  that 
contain  ITAM  (Fc~RI,  BCR,  and  TCR)  and  share  with 
FcyR most signaling events (14-16). No detectable MAPK 
activation,  instead,  follows  occupancy  of the  membrane 
GPI-anchor Fc',/RIIIB, and the mechanisms of signal trans- 
duction via FcyRIIIB (20), if any, remain unclear. 
Several  reports  indicate  the  involvement  of  p21 r"  in 
MAPK  activation  (for  a  review  see  reference  1),  and  in 
Fc-/R-mediated signaling (27).  Galandrini  et al.  (27)  dem- 
onstrated  that  Fc',/RIIIA induces  p21 r'-r activation  in  NK 
cells,  suggesting  that  this  is  one  of the  mechanisms  of 
MAPK  activation  via  Fc'yRIIIA in  NK  cells.  Additional 
data demonstrate that Fc~/RlllA-dependent  MAPK activa- 
tion in NK cells  occurs via a PI-3 kinase-dependent mech- 
anism  (Kanakaraj,  P.,  R.  Trotta,  and  B.  Perussia,  manu- 
script in preparation). Stimulation ofmacrophages with CSF-1 
and bacterial LPS induces MAPK activation via both p21 ..... 
dependent  and -independent  mechanisms  (52), and activa- 
tion of MAPK, upon IL-2 stimulation  in T  cells,  involves 
PI-3  kinase-dependent  and  -independent  pathways  (53). 
The possibility  that p21 r~' and PI-3 kinase  are  involved in 
inducing MAPK activation in  Fc~/RI- and Fc~/RIl-stimu- 
lated monocytes and PMN needs to be investigated. 
Transcription  of the  protooncogene  c-fos  is  rapidly  and 
Figure  7.  Effect of PD  098059 on  Fc'yR- 
induced TNF-cx mRNA accunmlation. THP-1 
(left)  and NK  cells (right)  were incubated (3i1 
rain, 37~  with  DMSO  (vehicle) (-)  or 3(} 
mM PD 098059 (+), and for 2 or 1.5 additional h, 
respectively, with EA or E, as described in Fig. 
6. Total RNA was extracted and subjected to 
Northern blot analysis using TNF-(x (top)  and 
132-microglobulin cDNA  (bottom),  Experiment 
representative of  three performed with identical 
results. 
1032  Fc~R-induced MAPK Activation and Gene Expression transiently induced in several cell types upon stimulation of 
hematopoietic  receptors  (e.g.,  TCR,  IL-2R)  (15,  54)  that 
activate MAPK, depending on induced phosphorylation of 
the transcription  factor Elk-1  by these kinases  (7).  c-fos as- 
sociates  in  the  nucleus  with  preexisting  c-jun  proteins  to 
form AP-1  transcription  factor (41).  Our data  show that 
c-fos mRNA expression is rapidly induced in NK and THP-1 
monocytic  cells  upon  binding  of immune  complexes  to 
Fc',/R and that MAPK activation is necessary for its induc- 
tion  upon  Fc~/R  occupancy,  as  demonstrated  using  the 
MEK-specific  inhibitor  PD  098059  (38),  which  prevents 
Fc~/R-dependent ERK2 activation (not shown). We previ- 
ously reported that FcyRIIIA stimulation induces increased 
AP-1  activity in NK cells (40).  Here we present additional 
and  direct  evidence  that  MAPK  are  signal-transducing 
molecules  necessary  for  the  transmission  of Fc~/R-origi- 
nated signals to the nucleus,  mediating in this way the ex- 
pression  of early  genes  (i.e.,  c-fos)  involved  in  transcrip- 
tional gene regulation. 
Our  previous  data  indicated  that  cytokine  gene  tran- 
scription upon Fc',/RIIIA stimulation in NK cells  occurs in 
a  Ca  2+  and  cyclosporin A-dependent  fashion  (40,  55).  In 
THP-1  cells,  inhibition  of Fc',/R-induced TNF-ci mRNA 
accumulation was observed using the tyrosine kinase inhib- 
itor herbimycin A  (21), thus supporting that early signaling 
events,  such  as  tyrosine  kinase  activation  and  [Ca2+]i  in- 
creases,  are essential  to induce TNF-o~ mRNA  expression 
via  Fc~/R  in  monocytes  and  NK  cells.  The  present  data 
demonstrate that MAPK are indispensable  to allow Fc~/R- 
induced TNF-o~ mRNA  accumulation, based on the dem- 
onstration that induced TNF-o~ mRNA  accumulation after 
Fc',/R-immune  complex  interaction  is  almost  completely 
inhibited upon pretreatment  of the cells with the MEK in- 
hibitor PD 098059. 
The  signaling  molecules,  targets  of MAPK,  involved 
in  TNF-ct  induction  have  not  been  analyzed.  However, 
the presence of an active AP-l-binding site in the TNF-~x 
promoter  (56),  and the  notion that  MAPK regulate  AP-1 
activity  (41),  strongly  suggest  that  AP-1  represents  a 
MAPK-inducible transcription factor necessary for TNF-o~ 
expression upon Fc~/R stimulation. Preliminary data in NK 
cells  also  indicate  that  IFN-y  expression  after  Fc2IRIIIA 
stimulation  is  MAPK dependent  (Kanakaraj  et  al.,  manu- 
script in preparation).  All together, our findings are consis- 
tent with the conclusion that MAPK play an essential role 
in  allowing  cytokine  production  in  each  leukocyte  type 
upon stimulation with immune complexes. It remains to be 
investigated whether other Fc~/R-mediated functions, e.g., 
phagocytosis and  cytotoxicity,  are  similarly  regulated  in  a 
MAPK-dependent way. 
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